Ridgewood Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-32
| Closed | -$5.89K | – | 205 |
|
|
2025
Q2 | $5.89K | Sell |
32
-25
| -44% | -$4.65K | ﹤0.01% | 584 |
|
|
2025
Q1 | $11.9K | Sell |
57
-8
| -12% | -$1.55K | 0.01% | 465 |
|
|
2024
Q4 | $11.5K | Hold |
65
| – | – | 0.01% | 474 |
|
|
2024
Q3 | $12.8K | Sell |
65
-92
| -59% | -$17.2K | 0.01% | 471 |
|
|
2024
Q2 | $26.9K | Buy |
+157
| New | +$26K | 0.01% | 408 |
|
|
2023
Q3 | – | Sell |
-1,200
| Closed | -$162K | – | 183 |
|
|
2023
Q2 | $162K | Buy |
1,200
+1
| +0.1% | +$147 | 0.09% | 192 |
|
|
2023
Q1 | $191K | Sell |
1,199
-155
| -11% | -$23.7K | 0.12% | 175 |
|
|
2022
Q4 | $219K | Buy |
+1,354
| New | +$208K | 0.16% | 168 |
|
|
2022
Q3 | – | Sell |
-1,486
| Closed | -$228K | – | 175 |
|
|
2022
Q2 | $228K | Hold |
1,486
| – | – | 0.18% | 155 |
|
|
2022
Q1 | $241K | Sell |
1,486
-10,533
| -88% | -$1.53M | 0.16% | 166 |
|
|
2021
Q4 | $1.63M | Hold |
12,019
| – | – | 1.03% | 15 |
|
|
2021
Q3 | $1.3M | Buy |
12,019
+1,110
| +10% | +$127K | 0.88% | 23 |
|
|
2021
Q2 | $1.23M | Sell |
10,909
-430
| -4% | -$48.4K | 0.79% | 31 |
|
|
2021
Q1 | $1.23M | Buy |
11,339
+494
| +5% | +$52.8K | 0.75% | 35 |
|
|
2020
Q4 | $950K | Hold |
10,845
| – | – | 0.75% | 34 |
|
|
2020
Q3 | $950K | Buy |
10,845
+1,244
| +13% | +$117K | 0.74% | 34 |
|
|
2020
Q2 | $943K | Buy |
9,601
+997
| +12% | +$87.8K | 0.78% | 30 |
|
|
2020
Q1 | $656K | Sell |
8,604
-45
| -0.5% | -$3.83K | 0.67% | 37 |
|
|
2019
Q4 | $766K | Buy |
8,649
+4
| +0% | +$332 | 0.54% | 53 |
|
|
2019
Q3 | $655K | Sell |
8,645
-39
| -0.4% | -$2.67K | 0.51% | 57 |
|
|
2019
Q2 | $631K | Buy |
8,684
+1,984
| +30% | +$156K | 0.49% | 55 |
|
|
2019
Q1 | $540K | Buy |
+6,700
| New | +$548K | 0.44% | 57 |
|
|
2018
Q1 | – | Sell |
-4,104
| Closed | -$397K | – | 149 |
|
|
2017
Q4 | $397K | Sell |
4,104
-9
| -0.2% | -$848 | 0.35% | 84 |
|
|
2017
Q3 | $365K | Sell |
4,113
-60
| -1% | -$4.57K | 0.35% | 86 |
|
|
2017
Q2 | $303K | Sell |
4,173
-48
| -1% | -$3.23K | 0.3% | 99 |
|
|
2017
Q1 | $275K | Buy |
4,221
+597
| +16% | +$37.5K | 0.3% | 93 |
|
|
2016
Q4 | $226K | Buy |
+3,624
| New | +$221K | 0.27% | 101 |
|
Other funds holding ABBV
Ridgewood Investments's ABBV Position: Q3 2025 in Review
Ridgewood Investments sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 32 shares — an estimated $5.89K sold.
Ridgewood Investments first reported a position in ABBV in Q4 2016 and held it in 27 quarters. The position peaked at $1.63M in Q4 2021. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Ridgewood Investments reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- Ridgewood Investments sold 32 AbbVie shares in Q3 2025, an estimated $5.89K.
- Ridgewood Investments first reported a position in AbbVie in Q4 2016 and held it in 27 quarters.
- Ridgewood Investments's AbbVie position peaked at $1.63M in Q4 2021.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.